Personalis

Personalis is a genomic data company focused on advancing personalized cancer therapies. Their platform leverages comprehensive genomic profiling to analyze tumor and immune system interactions. They provide pharmaceutical companies and researchers with insights into cancer biology and drug response. Personalis's technology combines whole-genome sequencing, RNA sequencing, and advanced analytics to identify biomarkers, neoantigens, and resistance mechanisms. The company aims to accelerate drug development and enable the selection of patients most likely to benefit from specific treatments. Personalis works in partnership with leading cancer centers and pharmaceutical companies to deliver precise and actionable genomic information, driving innovation in cancer care and improving patient outcomes through tailored therapeutic strategies.